Enjoy complimentary customisation on priority with our Enterprise License!
The Microdialysis Market size is forecast to increase by USD 77.3 million, at a CAGR of 5.25% between 2023 and 2028.
There is an increasing number of applications of microdialysis across the globe. The technique of microdialysis has been mainly used to monitor the concentrations of endogenous biomolecules in the brain since the 1970s. In addition, currently, the technique is mostly used to monitor the concentration of both endogenous and exogenous biomolecules in almost all tissues of the body. Moreover, Microdialysis is gaining prominence in pharmacodynamic and pharmacokinetic studies, both in humans and animals. With the growing use of microdialysis in pharmacokinetic studies. Hence, such factors are positively impacting the market.
Technavio has segmented the market into Product, End-user, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 - 2022, besides analyzing the current market scenario.
To learn more about this report, Download Report Sample
The microdialysis probes segment is estimated to witness significant growth during the forecast period. Microdialysis probes come in various types and designs, depending on the research needs. In addition, some of the most common types are hollow fiber microdialysis probes, concentrated microdialysis probes, and linear microdialysis probes. Furthermore, each type has its own unique characteristics that make it suitable for specific applications.
Get a glance at the market contribution of various segments Download PDF Sample
The microdialysis probes segment was the largest segment and was valued at USD 60.32 million in 2018. Moreover, microdialysis probes made from hollow fiber, for example, are well-known for their high rate of recovery and high rate of sampling. In addition, these probes are widely used in neurochemical studies, where precise measurements of neurotransmitters are essential. Furthermore, concentric microdialysis probes are more commonly used in pharmacokinetics studies, as they provide continuous, stable sampling over long periods of time. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
Microdialysis has a broad range of applications in hospitals and clinics, where precise and up-to-date information on a patient's vital signs is necessary for accurate diagnosis and treatment. In addition, microdialysis devices are used extensively in hospitals, particularly in critical care units (CCUs), surgery centers, and trauma centers. Moreover, microdialysis can provide real-time information on tissue metabolism and oxygenation, as well as other vital parameters, which is essential for the management of critically ill patients. Furthermore, the dynamic information provided by microdialysis allows clinicians to make informed decisions, resulting in better patient outcomes. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
Microdialysis probes are one of the most essential products for research laboratories in the global market. In addition, they are used by researchers to gain insight into dynamic changes in tissues over a long period of time, helping them understand biological processes better. Moreover, microdialysis systems including pumps and accessories are essential for continuous monitoring research laboratories. Furthermore, microdialysis systems play an essential role in controlling perfusion fluid flow rate via microdialysis probe, thus ensuring accurate and consistent data collection. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The large market share of North America is fuelled by the increasing focus on the significant research being undertaken on the brain and the presence of key market players based in the region. In addition, in North America, a significant number of people suffer from neurological and psychiatric disorders, such as Alzheimer's disease, Parkinson's disease, depression, sleep disorders, epilepsy, stroke, traumatic brain injury, and migraine, among others. Moreover, the National Institutes of Health (NIH) in the US is one of the largest neuroscience research centers in the world. In addition, it has more than 150 laboratories, originating from 11 different institutes, which are engaged in conducting research on neuroscience. Such governmental funding and support for research on the brain are expected to drive market growth in North America during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 11 market companies, including:
Amuza Inc: The company offers microdialysis such as Chronic Microdialysis, Acute Microdialysis, and others.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
One of the key factors driving the market growth is the advantages of microdialysis over other methods. The various techniques that are widely used for the sampling of extracellular fluid comprise microdialysis and push-pull perfusion. In addition, microdialysis offers a lot of advantages over the push-pull perfusion method, as it (microdialysis) does not involve the net flow of fluid either into or out of the microdialysis tubing.
Moreover, this prevents the surrounding tissue from getting damaged while maintaining functional integrity. In addition, this technique allows the filtration of molecules of only certain sizes through the semipermeable dialysis membranes. Furthermore, this allows the undesired substances, enzymes, and bacteria to be filtered out, which, in turn, eliminates the need for sterilization or additional separation techniques. Hence, such factors are driving the market growth during the forecast period.
A key factor shaping the market growth is the increasing focus on skin microdialysis. The market is witnessing an increasing emphasis on skin microdialysis, which is utilized for the recovery of soluble exogenous and endogenous biomolecules from the extracellular region of the human skin. In addition, skin microdialysis involves the insertion of thin, tubular dialysis membranes into the subcutis or the dermis of the skin and the perfusion of a physiological solution at a slow speed.
Moreover, soluble exogenous or endogenous biomolecules that are present in the extracellular fluid get diffused into the tubular microdialysis membrane, which is later collected in small vials for further analytical processes. In addition, as skin microdialysis is a minimally invasive procedure, the technique can be used in preclinical and clinical stages. Hence, such factors are driving the market growth during the forecast period.
The high cost of microdialysis technology is one of the key challenges hindering market growth. Even though commercial microdialysis probes are in high demand for monitoring pathological, pharmacological, and physiological changes in the cerebrospinal fluid, these probes can prove to be very costly for research assemblies in public institutions. In addition, the commercially available microdialysis equipment comes at a higher cost.
Moreover, the application of microdialysis is primarily limited to modern and off-line analysis and measurements in studies related to animal neurotransmitters in many developing countries. In addition, the limitations of the dialysis membrane probe have limited its technology applications in macromolecules and fat-soluble compounds. Hence, suhc factors are negatively impacting the market which in turn hinders the market growth during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
The market report forecasts market growth by revenue at global, regional & country levels and provides a market growth analysis of the latest market trends and analysis and growth opportunities from 2018 to 2028.
|
Microdialysis Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
164 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 5.25% |
|
Market Growth 2024-2028 |
USD 77.3 million |
|
Market structure |
Concentrated |
|
YoY growth 2023-2024(%) |
4.81 |
|
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
|
Performing market contribution |
North America at 44% |
|
Key countries |
US, Germany, UK, China, and Japan |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Amuza Inc., Bioanalytical Systems Inc., Charles River Laboratories International Inc., Harvard Bioscience Inc., Instech Laboratories Inc., M Dialysis AB, Medtronic Plc, Merck KGaA, Microbiotech se ab, Synaptics Inc., and Thermo Fisher Scientific Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.